NUTX - NASDAQ
Nutex Health, Inc.
$133.48
+6.8%Nutex Health, Inc. operates as a technology-enabled healthcare services company. It operates through two divisions: Hospital division and Population Health Management division. The Hospital division implements and operates health care models, including micro-hospitals, specialty hospitals, and hospital outpatient departments. This division owns and operates 21 facilities in 8 states. The Population Health Management division owns and operates provider networks, such as independent physician associations. Its management services organizations provide management, administrative, and other support services to its affiliated hospitals and physician groups. This division's cloud-based proprietary technology platform aggregates data across multiple information systems, settings, and sources to create a holistic view of each patient and provider, as well as allows to deliver care. The company is based in Houston, Texas.
At a Glance
Live SnapshotNutex Health, Inc. Profit Bridge
Profitability Analysis
Gross Margin
Exceptional pricing power and cost management. The company retains over half of revenue after direct costs.
Operating Margin
Outstanding operational efficiency. The company generates substantial profit from core operations.
Net Profit Margin
Moderate profitability with room for improvement. Monitor interest expenses and tax efficiency.
Effective Tax Rate
Higher tax burden may reflect limited tax optimization or operations in high-tax jurisdictions.
Profitability Insight
High margin compression: Large gap between gross and net margins suggests operational inefficiencies or heavy debt burden. Focus on expense management and deleveraging.
Nutex Health, Inc. Income Statement
NUTX • NASDAQ
| Nutex Health, Inc. Income Statement | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2011 | Dec 2010 | Dec 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
REVENUE | ||||||||||||||
875.3M | 479.9M | 247.6M | 219.3M | 331.5M | 274M | 97.1M | 91.4K | 53.6K | 0.0 | 0.0 | 2.5M | 1.3M | 220.5K | |
GROSS PROFIT | ||||||||||||||
(431M) | (283.7M) | (212.9M) | (203.9M) | (152.3M) | (116.4M) | (1.7M) | (62.3K) | (564.4K) | (473.0) | (662.0) | (1.5M) | (783.2K) | (94.9K) | |
444.3M | 196.3M | 34.8M | 15.4M | 179.3M | 157.6M | 95.4M | 29.1K | -510.7K | -473.0 | -662.0 | 1M | 483.2K | 125.6K | |
OPERATING INCOME | ||||||||||||||
(168.7M) | (65.6M) | (66.5M) | (422M) | (9M) | (4.4M) | (62.3M) | (1.8M) | (5.7M) | (448.1K) | (532.3K) | (1.9M) | (1.8M) | (809.5K) | |
(168.7M) | (58.6M) | (36.1M) | (20M) | (5.5M) | (4.4M) | (59.9M) | (1.2M) | (1.8M) | (448.1K) | (532.3K) | (1.9M) | (1.8M) | (809.5K) | |
(0.0) | (0.0) | (0.0) | (0.0) | (285.9K) | (0.0) | (768.1K) | (545.2K) | (25.6K) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | |
275.6M | 130.6M | -31.8M | -406.6M | 170.3M | 153.2M | 34.7M | -1.8M | -5.7M | -448.6K | -533K | -844.6K | -1.3M | -684K | |
PRE-TAX INCOME | ||||||||||||||
(22.2M) | (19.9M) | (16.3M) | (12.5M) | (6.2M) | (6.4M) | (3.5M) | -642.1K | -367.4K | (2.6K) | (3.1K) | (0.0) | (0.0) | (0.0) | |
-22.2M | -19.9M | -16.3M | -12.5M | -6.2M | -6.4M | -3.5M | 0.0 | 0.0 | -2.5K | -3.1K | 0.0 | 0.0 | 0.0 | |
(0.0) | (7.1M) | (30.5M) | (402M) | (3.3M) | (0.0) | (1.7M) | (633.6K) | (3.9M) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | |
-30.8M | -20.9M | -16.7M | -13M | -773.9K | -7.4M | -2.6M | -983.7K | -314.6K | -2.5K | -3.1K | 29.1K | 8.3K | 3.9K | |
244.8M | 109.7M | -48.5M | -419.6M | 169.5M | 145.7M | 32.1M | -2.8M | 582.1K | -451.1K | -536.1K | -815.4K | -1.3M | -680.1K | |
NET INCOME | ||||||||||||||
(64.4M) | (14.5M) | -5.1M | (13.1M) | (965.7K) | (181.3K) | (0.0) | -161.1K | -535K | (0.0) | (0.0) | -432K | -1.5M | -1.3M | |
70.8M | 52.2M | -45.8M | -424.8M | 132.6M | 106M | 16.5M | -2.8M | 582.1K | -7.4M | 83.8K | -383.4K | 158.1K | 605.3K |
SEC Filings
NUTX - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
10-Q 10-Q 2026 Q1 Q1 | April 30, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 30, 2026 | April 30, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 23, 2026 | April 23, 2026 | 2026 | |
DEF 14A DEF 14A 2026 N/A | March 13, 2026 | March 13, 2026 | 2026 | |
8-K 8-K 2026 N/A | March 05, 2026 | March 05, 2026 | 2026 | |
10-K 10-K 2025 FY FY | March 05, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2025 N/A | November 24, 2025 | November 24, 2025 | 2025 | |
8-K 8-K 2025 N/A | November 19, 2025 | November 19, 2025 | 2025 | |
10-Q 10-Q 2025 Q3 Q3 | November 19, 2025 | September 30, 2025 | 2025 | |
10-Q/A 10-Q/A 2025 Q1 (Amended) Q1 | November 18, 2025 | March 31, 2025 | 2025 |
Related Guides
Continue your NUTX research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.